LJI308, CAS [[1627709-94-7]]

Produktübersicht

• Artikelname: LJI308, CAS [[1627709-94-7]]
• Artikelnummer: MCE-HY-19713
• Hersteller Artikelnummer: HY-19713
• Alternativnummer: MCE-HY-19713-10MG,MCE-HY-19713-10MMX1ML,MCE-HY-19713-5MG,MCE-HY-19713-25MG,MCE-HY-19713-100MG,MCE-HY-19713-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

LJI308 is a potent pan-ribosomal S6 kinase (RSK) inhibitor, with IC50s of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively. LJI308 inhibits the phosphorylation of RSK (T359/S363) and YB-1 (S102) after irradiation, treatment with EGF, and in cells expressing a KRAS mutation[1][2].

Produkteigenschaften

• Molekulargewicht: 368.38
• Reinheit: 99.07
• CAS Nummer: [1627709-94-7]
• Formel: C21H18F2N2O2
• Target-Kategorie: Ribosomal S6 Kinase (RSK),YB-1

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound